フォロー
Salvador Resino (ORCID:0000-0001-8783-0450)
Salvador Resino (ORCID:0000-0001-8783-0450)
Head of laboratory (Centro Nacional de Microbiología - Instituto de Salud Carlos III)
確認したメール アドレス: isciii.es - ホームページ
タイトル
引用先
引用先
年
Persistence of proinflammatory response after severe respiratory syncytial virus disease in children
JF Bermejo-Martin, MC Garcia-Arevalo, A Alonso, RO De Lejarazu, ...
The Journal of allergy and clinical immunology 119 (6), 1547-50, 2007
2642007
Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19
JF Bermejo-Martin, M González-Rivera, R Almansa, D Micheloud, ...
Critical Care 24 (1), 1-13, 2020
2432020
A combined score of pro-and anti-inflammatory interleukins improves mortality prediction in severe sepsis
D Andaluz-Ojeda, F Bobillo, V Iglesias, R Almansa, L Rico, F Gandía, ...
Cytokine 57 (3), 332-336, 2012
2422012
Host adaptive immunity deficiency in severe pandemic influenza
JF Bermejo-Martin, I Martin-Loeches, J Rello, A Antón, R Almansa, L Xu, ...
Critical Care 14 (5), R167, 2010
2032010
Vitamin D in Human Immunodeficiency Virus Infection: Influence on Immunity and Disease
MÁ Jiménez-Sousa, I Martínez, LM Medrano, A Fernández-Rodríguez, ...
Frontiers in Immunology 9, 458, 2018
1942018
TRIM25 in the regulation of the antiviral innate immunity
M Martín-Vicente, S Resino, LM Medrano, A García-Sastre, I Martinez
Frontiers in Immunology 8, 1187, 2017
1492017
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ...
Nature 617 (7962), 764-768, 2023
1342023
Transcriptomic correlates of organ failure extent in sepsis
R Almansa, M Heredia-Rodríguez, E Gomez-Sanchez, D Andaluz-Ojeda, ...
Journal of Infection 70 (5), 445-456, 2015
1282015
Early natural killer cell counts in blood predict mortality in severe sepsis
D Andaluz-Ojeda, V Iglesias, F Bobillo, R Almansa, L Rico, F Gandía, ...
Critical Care 15 (5), R243, 2011
1222011
Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C
MA Jiménez-Sousa, A Fernández-Rodríguez, M Guzmán-Fulgencio, ...
BMC medicine 11 (1), 6, 2013
1102013
Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta‐analysis
M García‐Álvarez, D Pineda‐Tenor, MA Jiménez‐Sousa, ...
Hepatology 60 (5), 1541-1550, 2014
1072014
Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up
S Resino, R Resino, D Micheloud, D Gurbindo Gutiérrez, JA Léon, ...
Clin Infect Dis 42 (6), 862-9, 2006
1072006
Epidemiological trends of sepsis in the twenty-first century (2000–2013): an analysis of incidence, mortality, and associated costs in Spain
A Álvaro-Meca, MA Jiménez-Sousa, D Micheloud, A Sánchez-Lopez, ...
Population health metrics 16 (1), 4, 2018
902018
Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation
S Molina-Pinelo, A Vallejo, L Díaz, N Soriano-Sarabia, ...
Journal of Antimicrobial Chemotherapy 64 (3), 579-588, 2009
882009
Low Blood CD8^+ T-Lymphocytes and High Circulating Monocytes Are Predictors of HIV-1-Associated Progressive Encephalopathy in Children
S Sánchez-Ramón, JM Bellón, S Resino, C Cantó-Nogués, D Gurbindo, ...
PEDIATRICS-SPRINGFIELD- 111 (3), 421-421, 2003
852003
Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children
S Resino, R Resino, J Maria Bellón, D Micheloud, MD Gutiérrez, ...
Clin Infect Dis 43 (2), 243-52, 2006
832006
Predictive Markers of Clinical Outcome in Vertically HIV-1–Infected Infants. A Prospective Longitudinal Study
S Resino, D Gurbindo, JM Bellón, S Sanchez-Ramón, ...
Pediatric research 47 (4), 509-515, 2000
822000
CD38 Expression in CD8+ T Cells Predicts Virological Failure in HIV Type 1–Infected Children Receiving Antiretroviral Therapy
S Resino, JM Bellón, MD Gurbindo, MA Munoz-Fernández
Clinical infectious diseases 38 (3), 412-417, 2004
752004
Plasma miRNA profile at COVID-19 onset predicts severity status and mortality
A Fernández-Pato, A Virseda-Berdices, S Resino, P Ryan, ...
Emerging microbes & infections 11 (1), 676-688, 2022
682022
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV
J Medrano, K Neukam, N Rallón, A Rivero, S Resino, S Naggie, A Caruz, ...
Clinical infectious diseases 51 (10), 1209-1216, 2010
682010
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20